NephroPlus funding, investors and company details
NephroPlus is an emerging Healthcare - Hospitals and Clinic startup from Hyderabad, working in the space of Healthcare Services (Dialysis Care / Kidney Care Services). Founded by Vikram Vuppala, Kamal D Shah, Pullaiah Vuppala.
- Company: Nephrocare Health Services Limited
- Sector: Healthcare - Hospitals and Clinic
- Location: Hyderabad
- Founders: Vikram Vuppala, Kamal D Shah, Pullaiah Vuppala
- Total funding raised: ₹850 Cr
Company overview
NephroPlus (operated by Nephrocare Health Services Limited) is a healthcare service provider specializing in dialysis care for patients with chronic kidney disease (CKD). Its core business revolves around delivering affordable, high-quality dialysis treatments through a large network of centers across India and international markets. The company primarily operates a dialysis center network model, where it runs facilities in three formats, Hospital-based units (outsourcing model): Managing dialysis centers hospitals, Public-Private Partnerships (PPP): Collaborating with government hospitals to provide subsidized dialysis, Standalone clinics: Independently operated dialysis centers This diversified model allows NephroPlus to scale rapidly while maintaining an asset-light and capital-efficient approach. At the core of its offering is in-clinic haemodialysis, supported by standardized protocols, trained medical staff, and advanced equipment to ensure consistent treatment quality. The company also provides holistic kidney care services, including diet guidance, patient counseling, and technology-enabled engagement through mobile apps and monitoring systems. A key differentiator of NephroPlus is its patient-centric approach, where patients are treated as “guests,” focusing on comfort, convenience, and quality of life during long-term treatment. From a business perspective, NephroPlus benefits from, Recurring demand: Dialysis is a life-sustaining treatment required multiple times per week, High entry barriers: Requires clinical expertise, regulatory compliance, and infrastructure, Partnership-driven growth: Strong ties with hospitals, nephrologists, and governments. The company has also expanded internationally (Philippines, Uzbekistan, etc.), evolving into a multi-country dialysis network and positioning itself as one of Asia’s largest providers in this segment. Overall, NephroPlus’s business is centered on scalable, technology-enabled dialysis services delivered through partnerships and a distributed clinic network, making it a leader in the chronic kidney care ecosystem.
Funding rounds
- Latest round: ₹850.00 Cr. ($ 101.89 Mn), 2024-05-07. Investors: Quadria Capital